Geoffrey Kim, M.D.

Before becoming Vice President of Applied Innovation at BeiGene, Dr. Kim was Vice President, Oncology and Head of Oncology Strategic Combinations at AstraZeneca from July 2017 – July 2019.

He was Director, Division of Oncology Products 1, at the U. S. Food and Drug Administration from March 2015 – July 2017. Prior to that, he was a Medical Officer at the FDA. 

Dr. Kim received his medical degree from New York Medical College.